FilingSEC EDGAR6-K
Chemomab Therapeutics Amends Merger Agreement and CVR Agreement
· SEC accepted
StageMerger in progress
Filing content
Chemomab Therapeutics amended its merger agreement with Scipher Medicine and adjusted the CVR agreement regarding information rights and payment mechanics.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…